The forecast for leukemia mortality in Mexico, expressed as deaths per hundred thousand persons standardized rates, remains constant at 5.0 for the years 2024 through 2028. In 2023, the value also stood at 5.0, indicating no year-on-year variation in percentage for the past two years. Over the last five years, the compound annual growth rate (CAGR) also registers as stable, showing no average annual variation.
Future trends to watch for include advancements in medical treatments and healthcare interventions which could impact leukemia mortality rates. Additionally, changes in public health policies and increased investments in cancer research could also influence mortality outcomes.
